Navigation Links
Mesa Labs Reports Higher Quarterly Sales and Earnings
Date:2/10/2009

or the first nine month period, net income increased five percent while earnings per diluted share increased by seven percent for the period.

During the first nine months of fiscal 2009, the Company repurchased 5,315 shares of our common stock under a previously announced buyback plan for approximately $106,000. In addition, the Company has a remaining commitment of approximately $236,000 for automation of certain manufacturing processes for its Raven line of biological indicators. This equipment began limited production during December and final payment against this commitment is expected during the fourth quarter.

Mesa Laboratories develops, acquires, manufactures and markets electronic instruments and disposables for industrial, pharmaceutical and medical applications.

This news release contains forward-looking statements which involve risks and uncertainties. The Company's actual results could differ materially from those in any such forward-looking statements. Additional information concerning important factors that could cause results to differ materially from those in any such forward-looking statement is contained in the Company's Annual Report on Form-10K for the year ended March 31, 2008 as filed with the Securities and Exchange Commission, and from time to time in the Company's other reports on file with the Commission.

                                 FINANCIAL SUMMARY

    STATEMENT OF EARNINGS (Unaudited)
                                 Quarter Ended          Nine Months Ended
                                  December 31             December 31
                               2008         2007        2008         2007
    Net Sales               $5,337,000  $4,614,000 $16,071,000 $13,768,000
    Cost of Goods            1,903,000   1,527,000   5,786,000   4,494,000
    Gross Profit             3,434,000   3,087,000  10,285,000   9,274,000
    Opera
'/>"/>
SOURCE Mesa Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008
2. Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results
3. NADP Study Reports Dramatic Increase in Value of Dental Benefits
4. The Female Health Company Reports First Quarter Operating Results, as Gross Profit Margins Widen on Increasing Sales of FC2 Female Condom(R)
5. Cynosure Reports Financial Results for the Fourth Quarter and Full Year 2008
6. Allied Healthcare Reports Second Quarter Loss
7. Immtech Reports Fiscal Third Quarter 2009 Results
8. Misonix Reports Earnings and Increased Revenues for the Three and Six Months Ended December 31, 2008
9. ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients
10. Chindex International, Inc. Reports Third Quarter FY 2009 Financial Results
11. Bioniche Reports Fiscal 2009 Second Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015 The U.S. Pharmacopeial Convention is ... of Clinical Pharmacy Services at North Carolina State’s College ... the 2015 Beal Award for Distinguished Volunteer Service—the organization’s ... on the contributions of volunteer experts to direct its ...
(Date:1/22/2015)... Woodloch Pines, an all-inclusive family resort ... TripAdvisor as the number one best large hotel for families ... world for their annual Travelers’ Choice Awards. , TripAdvisor ... website is home to millions of unbiased and honest traveler ...
(Date:1/22/2015)... The Incredible Bulk is a revolutionary method ... lean muscle by up to 30lbs in less than 12 ... HealthyandFitZone.com’s Stan Stevenson, prompting an investigative review. , “Our ... scientific diet formula that allows the body to pack on ...
(Date:1/22/2015)... New York, New York (PRWEB) January 22, 2015 ... ( http://www.vaginalmeshlawsuit2015.com/ ) in the U.S. District Court, Southern District ... against C.R. Bard, Inc. in that proceeding’s first bellwether trial. ... defense request for a new trial after finding that C.R. ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Autocarinsurancebest.com has released ... purchasing a commercial auto insurance policy . , Auto ... their vehicles. It is no longer necessary to call an ... are now available online on a single website: http://autocarinsurancebest.com/ ...
Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2
... the profile for the usage of long-acting contraceptive methods. ... award, shows, amongst other things, that 10% of women ... "Long-acting contraceptives (the IUD, contraceptive injection or contraceptive ... at the Hospital del Mar in Barcelona and author ...
... eyestrain, poor posture, study finds , WEDNESDAY, Oct. 28 ... reduce the level of pain linked to poor posture ... just assume that problems will be solved by purchasing ... It,s also important to make sure the furniture is ...
... A clinical trial for ... Oak, and will open soon at the University of Michigan Comprehensive Cancer Center in Ann Arbor, ... ... women with an aggressive form of metastatic breast cancer is now open at Beaumont Hospital, ...
... ... supplement delivers enhanced speed, growth and productivity while replacing undefined media components such as ... ... 2009 -- InVitria presented the successful performance of its newest CHO cell culture ...
... 28 Two-time Major League Baseball (MLB) Manager ... featured on this month,s episode of Sharing Miracles - ... compelling and inspirational stories of real patients. Sharing Miracles ... stations nationwide. , An iconic figure in baseball, Torre ...
... Minn., Oct. 28 NeuroVasx, Inc., a medical device ... and ischemic stroke, announced today that the first procedure ... performed in Madrid. cPAX received CE Mark earlier this ... Endovascular and Percutaneous Treatment, Clinica Nuestra Senora del Rosario, ...
Cached Medicine News:Health News:The IUD is the most popular long-acting contraceptive amongst Europeans 2Health News:Takes a Pro to Make Offices Pain-Free 2Health News:Beaumont, U-M Open Study of Drug for Advanced Breast Cancer 2Health News:Beaumont, U-M Open Study of Drug for Advanced Breast Cancer 3Health News:Beaumont, U-M Open Study of Drug for Advanced Breast Cancer 4Health News:InVitria Reports Successful Cell Culture Performance of Zap-CHO, a Defined and Cost Effective CHO Cell Culture Media Supplement 2Health News:'Sharing Miracles' Television Program to Feature Baseball Manager, Cancer Survivor Joe Torre 2Health News:'Sharing Miracles' Television Program to Feature Baseball Manager, Cancer Survivor Joe Torre 3Health News:'Sharing Miracles' Television Program to Feature Baseball Manager, Cancer Survivor Joe Torre 4Health News:'Sharing Miracles' Television Program to Feature Baseball Manager, Cancer Survivor Joe Torre 5Health News:'Sharing Miracles' Television Program to Feature Baseball Manager, Cancer Survivor Joe Torre 6Health News:'Sharing Miracles' Television Program to Feature Baseball Manager, Cancer Survivor Joe Torre 7Health News:NeuroVasx Announces First Case of cPAX Aneurysm Treatment System in Spain 2Health News:NeuroVasx Announces First Case of cPAX Aneurysm Treatment System in Spain 3
(Date:1/23/2015)... 23, 2015  HyGreen, Inc., a leader in hand hygiene ... RCA Medical, a subsidiary of Ascendis Health Limited, in ... Each year, hundreds of millions of patients around the ... are transmitted from patient to patient via the unwashed ...
(Date:1/23/2015)... Jan. 23, 2015 Cord Blood America, Inc. ( www.cordblood-america.com ... the "Company")  filed a Preliminary Proxy Statement, Schedule 14A, with ... and provides an update for shareholders detailing why a "YES" ... Dear Shareholders, As we reflect upon ...
(Date:1/23/2015)... Gem Pharmaceuticals announced today that the initial soft tissue ... Phase 2 clinical trial.  This open-label study will assess ... (an investigational medication), in approximately 30 adults as first-line ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO GPX-150 is ...
Breaking Medicine Technology:HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2
... ,, WEST ORANGE, N.J. , May 25 Corneal Associates ... eye care technology.   Dr. Theodore Perl , the visionary surgeon and ... New Jersey the newest innovation in refractive surgery: the iFS™ Advanced Femtosecond ... (Logo:  http://www.newscom.com/cgi-bin/prnh/20100525/DA08463LOGO) , ...
... May 25 Phreesia, the leading patient check-in ... Series D investment. Ascension Health Ventures (AHV) led the ... Industries, Polaris Venture Partners, HLM Venture Partners, and Long River ... Investment Manager at Ascension Health Ventures, will be joining Phreesia,s ...
Cached Medicine Technology:iFS(TM) LASIK at Corneal Associates of New Jersey 2iFS(TM) LASIK at Corneal Associates of New Jersey 3Phreesia to Accelerate Growth with $16 Million Investment Led by Ascension Health Ventures 2Phreesia to Accelerate Growth with $16 Million Investment Led by Ascension Health Ventures 3
Mastisol Liquid Adhesive is a clear, non-irritating, and non-water-soluble liquid adhesive that secures the most difficult dressings for an extended period of time. Mastisol is 7 to 10 times stickier...
... Indermil® tissue adhesive is indicated for the ... incisions, and trauma-induced lacerations in areas of ... and have easily approximated skin edges. In ... adhesive may act as a barrier to ...
The first Ethyl-2-Cyanoacrylate tissue adhesive in a tube that is more economical than sutures!...
... GE Healthcare is ... in best-in-class analysis programs ... area monitoring device. With ... 12SL, Gender-Specific, and ACI-TIPI, ...
Medicine Products: